Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Day

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Molecular Imaging and Biology|December 15, 2011
Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft modelSarah R Mudd, Kimberley D Holich, Martin J Voorbach, et al.
Plos One|January 26, 2013
Imaging conditioned fear circuitry using awake rodent fMRINichola M Brydges, Heather C Whalley, Maurits A Jansen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 2008
Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1Sanbing Shen, Bing Lang, Chizu Nakamoto, et al.
Neuroimage|September 18, 2012
Pharmacological modulation of brain activity in a preclinical model of osteoarthritisJaymin Upadhyay, Scott J Baker, Rajasimhan Rajagovindan, et al.
Nature Neuroscience|February 26, 2008
Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memoryFeng Liu, Mark Day, Luis C Muñiz, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2008
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activitiesFeng Liu, Steve Grauer, Cody Kelley, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2008
Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)Warren D Hirst, Terrance H Andree, Suzan Aschmies, et al.
Journal of Medicinal Chemistry|May 7, 2010
The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonistsWayne E Childers, Lisa M Havran, Magda Asselin, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Molecular Imaging and Biology|December 15, 2011
Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft modelSarah R Mudd, Kimberley D Holich, Martin J Voorbach, et al.
Plos One|January 26, 2013
Imaging conditioned fear circuitry using awake rodent fMRINichola M Brydges, Heather C Whalley, Maurits A Jansen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 2008
Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1Sanbing Shen, Bing Lang, Chizu Nakamoto, et al.
Neuroimage|September 18, 2012
Pharmacological modulation of brain activity in a preclinical model of osteoarthritisJaymin Upadhyay, Scott J Baker, Rajasimhan Rajagovindan, et al.
Nature Neuroscience|February 26, 2008
Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memoryFeng Liu, Mark Day, Luis C Muñiz, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2008
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activitiesFeng Liu, Steve Grauer, Cody Kelley, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2008
Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)Warren D Hirst, Terrance H Andree, Suzan Aschmies, et al.
Journal of Medicinal Chemistry|May 7, 2010
The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonistsWayne E Childers, Lisa M Havran, Magda Asselin, et al.
Pageof 4